Researchers of a metagenomic analysis assessed the taxonomic and functional signatures of the gut microbiome in gout and its association with clinical parameters and response to therapeutic interventions.
Researchers compared the time to complete resolution of acute gout flare between early and late allopurinol initiation.
In an interview, Brian LaMoreaux, MD, MS, discusses the need for evidence-based strategies to improve outcomes for patients hospitalized with gout.
Using a population-based cohort, researchers assessed the effects of gout on risk for cardiovascular disease in patients with psoriasis.
Patients with asymptomatic hyperuricemia who achieved serum uric acid levels of 6.0 mg/dL or less while on urate-lowering therapy had fewer gout flare episodes, a study found.
Researchers developed and validated a gout flare risk stratification tool for patients with gout who were hospitalized for nongout conditions.
Each 1 mg/dL rise in uric acid level was significantly associated with a 21% and 10% increased risk for cardiovascular and all-cause mortality, respectively, a study found.
Researchers characterized peripheral vascular plaques that were color-coded as monosodium urate deposition by DECT, and assessed their association with MSU crystal burden in soft tissues.
Hyperuricemia and gout may be associated with a lower risk for Alzheimer disease.
A case study of a patient who developed an acute gout flare of bilateral first metatarsophalangeal joints after initiating treatment with ibrutinib for chronic lymphocytic leukemia.